(PharmaNewsWire.Com, September 11, 2017 ) Bone and Cartilage are both specialised forms of connective tissue and are made up of cells in an extracellular matrix. The properties of these connective tissues are defined by the nature of the matrix.
Cartilage is thin, avascular, flexible and shows resistance to compressive forces. Hyaline Cartilage is the most widespread type of cartilage and makes up the embryonic skeleton. The main function of cartilage is connecting bones together. It is found in the human body in areas like ear, nose, throat, rib cage and between the bones of the back.
The growth of the North American Cartilage Regeneration Market is mainly driven by factors such as increasing incidence of joint & bone disorders and the growing aging population with related connective tissue ailments, couples with the wide availability of cartilage repair products. Furthermore, rapid increase in the obese population and escalating frequency of injuries in sports & other accidents are set to boost market growth in the future. However, discouraging compensation policies and the extraordinary cost of cartilage therapy are the major restraints of market growth.
The North America Cartilage Regeneration Market is segmented on the basis of the Type of Treatment, Application and Geography. Based on the Type of Treatment used, the Cartilage Regeneration market is divided into Cell Based Approaches and Non-Cell Based Approaches. The Cell based Approaches are further divided into Chondrocyte Transplantation, Stem Cells and Growth Factor Technology. Non-cell based approach is further classified into Tissue Scaffolds and Cell-free composites. Based on Application, the Cartilage Regeneration Market is segmented into Hyaline Cartilage Regeneration and Fibrocartilage Regeneration.
The North American market has been geographically segmented into segmented into US and Canada. North America took the major chunk of the Global Cartilage Regeneration Market share in 2016, along with the highest global CAGR of more than 16%. Swift introduction of new cartilage repair or regeneration procedures driven by the increasing incidence bone & join disorders owing to age and injuries are driving the North American Cartilage Regeneration Market. The presence of major global market players in North America is a plus for market growth in this region.
The important players in the North America Cartilage Regeneration Market are Zimmer Biomet Holdings, Inc. (U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.), and Arthrex Inc. (U.S.).
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
